The U.S. Food and Drug Administration (FDA) has approved AbbVie's VYALEV (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based...
The U.S. Food and Drug Administration (FDA) has approved Pfizer's HYMPAVZI (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes...
Lundbeck is set to acquire Longboard Pharmaceuticals.
Under the terms of the agreement, Lundbeck will commence a tender offer for all outstanding shares of Longboard...